Parkinson's disease is a chronic degenerative disorder of the _________ that produces _______ problems
CNS
movement
What is the cause of PD?
unknown
Primary or idiopathic PD thought to have ______ and ______ factors
genetic
environmental
T/F: exposure to specific viruses and toxins can damage cells and activate PD
True False
True
Characteristics of secondary PD (not true PD)
(7)
encephalitis/meningitis
stroke
vascular disease
exposure to toxins
antipsychotic medications
over-dose of narcotics
repeated chronic head trauma
Risk factors of PD (4)
age
gender
genetic
exposure to environmental toxins
Incidence/prevalence of PD
increases with age
men are more likely to develop PD
PD is the disruption of which motor system?
extrapyramidal motor system
Pathophys of PD
substania nigra in basal ganglia contain dopamine, dopamine is an inhibitory NT that controls movement, cells that have decreased dopamine become overly excited
Overly excited neurons cause what?
movement and postural abnormalities
Lewy bodies are what?
clumps of proteins found in the brain of most PD patients
result from decreased NE
Early signs/symptoms (5) of PD
fatigue
muscle weakness
muscle aching
decreased flexibility
less spontaneous change in facial expression
Clinical features (5) of PD
pill rolling
increased muscle rigidity
difficulty initiating movements
bradykinesia
loss of automatic movements
Tremors (affect where first?)
affect hands, arms, leg first
then progress to jaw tongue forehead eyelids
PD posture
stooped, leaning forward, head and neck flexed
non-motor functions
dysarthria
voice low
chewing/swallowing issues
masked face
pain
memory loss
co-morbidities (4) of PD
dementia
UTI/ respiratory infections
depression/anxiety
disturbed sleep, fatigue
Tests of PD
currently no diagnostic tests but can use MRI, EEG, CAT
Stages of PD (5)
1-unilateral
2-bilateral
3-balance problems develop, ambulate w/o assistance
4-assistance needed during ambulation
5-w/c bound
Sub-types of PD
juvenile-extremely rare
early onset-rare
prognosis of PD
no cure
case by case basis
treatments of PD
meds (levidopa, dopamine agonists, anti-cholinergics, MAO-Binhibs, NMDA, glutamate)
deep brain stimulation-brain pacemaker
PT/OT
causes of Alzheimers
exact cause is unknown
genetic, environmental, lifestyle factors can contribute
mutations on which chromosomes contribute to Alzheimers?
1, 14, 21, 19
T/F: People with Down syndrome have an increased chance in developing Alzheimers?
True False
True
which lifestyle factors can contribute to Alzheimers?
obesity, smoking, diabetes, stress
Environmental factors which can cause Alzheimers?
viruses, metals (zinc, aluminum)
Prevalence of Alzheimers
1 in 8 people over 65 has AD
more women then men
more education = less chance for AD
7 stages of AD
1-none 2-very mild cognitive decline 3-mild cognitive decline (friends family become aware of decline) 4-moderate cognitive decline-(detectable by medical interview) 5-moderately severe cognitive decline-noticeable gaps in memory/thinking, need assistance w/ ADLs 6-severe cognitive decline-decline in memory, may have personality changes 7-very severe cognitive decline-
amyloid plaques
beta-amyloid proteins
found in extracellular CNS
stimulates production of free radicals
neurofibrillary tangles
tau proteins
lead to cell death
NT's affected
decrease in Ach in baslis nucleus of meynert
decrease in serotonin in median raphe
decrease in NE in locus cerulues
Tests of AD
only true test is by an autopsy
Early signs of AD
language problems (foregetting names of common things)
forgetting where you placed an object
lost on familiar trips
personality changes/social impairments
loss of interests
middle signs of AD
forgetting details about current events/past events
change in sleep patterns
reading/writing impairments
aphasia
increased difficulty with ADLs
severe AD
cant understand language
cant recognize family members
cant perform ADLs
subtypes of AD
early onset -progresses rapidly appears before 60 hereditary link
late onset -more common develops after 60 may be hereditary
co-morbidities of AD
depression
dysphagia
muscle contractures
broken bones
loss of social instabilities
treatments of AD
Ach esterase
Memantine
Vitamin E
TENS
PT/OT/SLP
background of MS
demyelination of brain, spinal cord, cranial nerves
characterized by remissions, exacerbations
etiology of MS
unknown cause but may appear as autoimmune
has genetic, immunlogic and environmental components
viral infections
climate can impact a person
incidence/prevalence of MS
more common in white people
more common in women
occurs between 20-40
Relapsing-remitting MS
most common form
characterized by exacerbations and remissions followed by partial or complete recovery
85% of people being with this one
Primary progressive MS
progression of disability from onset without plateaus of remissions but can have periods of stabilization
does not experience acute attacks
10-15% people with MS have this
Secondary progressive MS
begins as relapsing remitting followed by progression of disability that may include occasional relapses , minor remissions and plateaus
of the 85% that start out as RRMS more than 50% will develop SPMS within 10 years, 90% within 25 yrs
progressive-relapsing MS
least common
shows progression of disability from onset but with clear acute relapses with w/o full recovery
5% of people have this
Pathophys of MS
autoimmune
loss of myelin sheath causing loss of saltatory conduction
affects all types of nerve fibers: sensory and autonomic
earliest lesions occur as inflammation of myelin sheath lost in white matter of brain and spinal cord
plaques are what and where are they found?
seen in lateral ventricles of brain, brain stem and optic nerve
larger areas of inflammation and demyelination
Testing for MS
history
neuro exam
visual/auditory/somatosensory testing
MRI
lumbar puncture
Clinical features of MS
blurred vision is common 1st sign due to plaques on corticospinal tract
diplopia, nystagmus, vertigo,
numbness, tingling, tightness
pain
progressive weakness, paralysis in UE
motor symptoms of MS
paraperesis or paraplegia more common than UE weakness
spasticity more common in legs than arms
amyotrophy can occur
coordination symptoms of MS
gait imbalance
slurred speech
co-morbidities of MS
depression
complications of immobility
respiratory infections
bed sores
contractures
Treatments of MS
no specific treatment at this time
medications (corticosteroids,beta interferons, copaxone, tysabri,novantrone)
plasma exchange
PT/OT/
Goals of MS (4)
improve speed of recovery from attacks
reducing number of attacks and lesions
slow progression of disease
find relief from other complications
What happens to nerve axons of patients with MS during remission?
limited remyelination
definition of ALS is....?
progressive neurodegenerative disease that attacks nerve cells in the brain and spinal cord resulting in muscle weakness and atrophy
amyotrophic =?
muscle wasting
sclerosis =?
hardening of the lateral corticospinal tract
cause of ALS
90% is unknown
10% genetic
Incidence of ALS
40-60 yrs old
environment
genetics
smoking, family history
males more likely to have it than females
whites more common
course of ALS
no 2 people go through the same course of ALS
death usually occurs within 3-5 years
ALS is a _________ disease
neurodegenerative
ALS degenerates both _________ and ________motor neurons
upper and lower
as motor neurons degenerate the anterior and lateral columns of the spinal cord are replaced by fibrous ______ causing hardening of these areas
astrocytes
Wallerian Degeneration =?
process by which motor axons die
death in anterior horn of cell body
degeneration of associated motor axons
Schwann cells break down myelin
axon breaks into pieces
macrophages clean up axon
Upper motor neurons
degeneration of corticospinal upper motor neurons
loss of these leads to: spastic paralysis hyperreflexia stiffness
lower motor neurons
degeneration of lower motor neurons that reside in anterior horn of spinal cord and in brainstem
loss of these leads to: flaccid paralysis decreased muscle tone decrease reflexes muscle weakness muscle atrophy
progressive bulbar palsy
bulbar involvment (facial muscles)
progressive muscle atrophy
pure lower motor neuron degeneration
primary lateral sclerosis
pure upper motor neuron degeneration
ALS do not affect (4)
1-cranial nerves
2-sensory neurons
3-cognitive function
4-bowel and bladder function
diagnostic tests for ALS
determined by ruling out all other tests
family history, lab tests, CT/MRI, EMG, blood tests, gene testing
early stage clinical features of ALS
painless, weakness and difficulty breathing
soft/spastic muscles
twitches
atrophy of muscles
localized or sporadic symptoms
muscle imbalance
weak grip
middle stage features of ALS
symptoms worsen
muscle paralysis
contractures
joint pain/deformity
difficulty swallowing
final stage clinical features of ALS
paralysis of voluntary muscles
severe breathing insufficiency
susceptible to lung infections
speech failure
problems eating/speaking due to dysphagia
death after 3-5 years
Sporadic ALS
most common form
accounts for 90-95% reported cases
Familial ALS
gene related
connected to defective gene on chromosome 21
Guamanian ALS
extremely high incidence in Guam
co-morbidities
anxiety
weight loss
fatigue
aspiration
pneumonia
depression
pressure sores
lung failure